Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to Niacin (Q58123851)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

title

Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to Niacin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

author name string

Sony Tuteja

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Liming Qu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Richard L Dunbar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Jinbo Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Stephanie DerOhannessian

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Daniel J Rader

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

language of work or name

English

0 references

publication date

1 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

30 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

page(s)

e03488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

30 April 2020

cites work

1 reference

12 December 2020

Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man.

1 reference

12 December 2020

RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo

1 reference

12 December 2020

Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol

1 reference

12 December 2020

Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment

1 reference

12 December 2020

Effect of very-low-dose niacin on high-density lipoprotein in patients undergoing long-term statin therapy

1 reference

12 December 2020

Hepatic lipase, lipoprotein metabolism, and atherogenesis

1 reference

12 December 2020

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

1 reference

12 December 2020

Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review

1 reference

12 December 2020

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

12 December 2020

Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.

1 reference

12 December 2020

SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap

1 reference

12 December 2020

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction

1 reference

12 December 2020

Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin

1 reference

12 December 2020

Extended-release niacin or ezetimibe and carotid intima-media thickness.

1 reference

12 December 2020

Genetic variants associated with Lp(a) lipoprotein level and coronary disease

1 reference

12 December 2020

Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids

1 reference

12 December 2020

The relative importance of CYP26A1 in hepatic clearance of all-trans retinoic acid

1 reference

12 December 2020

Retinoid pathway and cancer therapeutics

1 reference

12 December 2020

Biological, clinical and population relevance of 95 loci for blood lipids

1 reference

12 December 2020

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

1 reference

12 December 2020

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

12 December 2020

Meta-analysis identifies six new susceptibility loci for atrial fibrillation

1 reference

12 December 2020

Extended-release niacin acutely suppresses postprandial triglyceridemia

1 reference

12 December 2020

The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits

1 reference

12 December 2020

Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate

1 reference

12 December 2020

GPR109A and vascular inflammation

1 reference

12 December 2020

Recent advances in niacin and lipid metabolism.

1 reference

12 December 2020

Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).

1 reference

12 December 2020

The role of retinoic acid in hepatic lipid homeostasis defined by genomic binding and transcriptome profiling

1 reference

12 December 2020

Discovery and refinement of loci associated with lipid levels

1 reference

12 December 2020

Oral retinoids and plasma lipids

1 reference

12 December 2020

High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm

1 reference

12 December 2020

Effects of extended-release niacin with laropiprant in high-risk patients

1 reference

12 December 2020

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins

1 reference

12 December 2020

Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease

1 reference

12 December 2020

Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors

1 reference

12 December 2020

Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

1 reference

12 December 2020

Meta-analysis of genome-wide association studies of HDL cholesterol response to statins

1 reference

12 December 2020

A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms

1 reference

12 December 2020

Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy

1 reference

12 December 2020

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

1 reference

12 December 2020

Identifiers

DOI

10.1161/JAHA.117.008461

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30371334%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

PubMed publication ID

30371334

1 reference